Seoul Pharma Co Ltd (018680)

Currency in KRW
3,385
+50(+1.50%)
Closed·
018680 Scorecard
Full Analysis
Trading at a low Price / Book multiple
018680 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,3253,390
52 wk Range
2,9705,930
Key Statistics
Bid/Ask
3,370.00 / 3,385.00
Prev. Close
3,335
Open
3,325
Day's Range
3,325-3,390
52 wk Range
2,970-5,930
Volume
4.78K
Average Volume (3m)
56.14K
1-Year Change
-39.66%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
018680 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Seoul Pharma Co Ltd Company Profile

Seoul Pharma Co., Ltd manufactures and sells pharmaceutical products in South Korea and internationally. The company offers orally disintegrating film products for therapeutic areas, including urology, neurology, nutrition, endocrinology, and OB/GY. Its products include VULTEUM and VULTIS for erectile dysfunction; ARTPEZIL for Alzheimer’ disease; OBCARE to treat overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency; and CH.V, as well as products for schizophrenia, vitamin supplement, obesity, tonic, and menopausal syndrome. The company also provides Ator for high blood pressure treatment; Flavel to treat stroke; Axated, a peptic ulcer medication; Crestin to treat hyperlipidemia; and Weltmin and Fendigene for the treatment of obesity. It also owns patents to orally dispersible films. The company was founded in 1976 and is headquartered in Cheongju-si, South Korea.

Employees
172

Compare 018680 to Peers and Sector

Metrics to compare
018680
Peers
Sector
Relationship
P/E Ratio
41.9x5.6x−0.5x
PEG Ratio
0.830.010.00
Price/Book
1.0x0.7x2.6x
Price / LTM Sales
0.7x0.8x3.3x
Upside (Analyst Target)
-32.1%40.3%
Fair Value Upside
Unlock19.9%5.1%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
-14.08 / --
Revenue / Forecast
12.89B / --
EPS Revisions
Last 90 days

018680 Income Statement

FAQ

What Stock Exchange Does Seoul Pharma Trade On?

Seoul Pharma is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Seoul Pharma?

The stock symbol for Seoul Pharma is "018680."

What Is the Seoul Pharma Market Cap?

As of today, Seoul Pharma market cap is 39.47B.

What Is Seoul Pharma's Earnings Per Share (TTM)?

The Seoul Pharma EPS (TTM) is 80.77.

From a Technical Analysis Perspective, Is 018680 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Seoul Pharma Stock Split?

Seoul Pharma has split 1 times.

How Many Employees Does Seoul Pharma Have?

Seoul Pharma has 172 employees.

What is the current trading status of Seoul Pharma (018680)?

As of 16 Aug 2025, Seoul Pharma (018680) is trading at a price of 3,385.00, with a previous close of 3,335.00. The stock has fluctuated within a day range of 3,325.00 to 3,390.00, while its 52-week range spans from 2,970.00 to 5,930.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.